Maternal Preeclampsia and Risk for Cardiovascular Disease in Offspring

Current Hypertension Reports

Volumn 16, Issue 9, 2014, Pages 1-10

  Herrera Garcia, Guadalupe ^a   Contag, Stephen ^a  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

Cardiovascular disease; Cardiovascular risk; Gestational hypertension; Hypertensive disease in pregnancy; Metabolic syndrome; Offspring; Preeclampsia

Indexed keywords

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HEALTH; HUMAN; INCIDENCE; NEWBORN; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PROGNOSIS; RISK FACTOR;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; GLOBAL HEALTH; HUMANS; INCIDENCE; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS; RISK FACTORS;

EID: 84939890238     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-014-0475-3     Document Type: Review

References (99)

1. CDC health disparities and inequalities report. United States, 2013, in MMWR Centers for Disease Control and Prevention: Atlanta, GA. 2013. p. 144–8.
2. Go AS et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–292.
3. Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. National Vital Statistics Reports; 2014. p. 61.
4. Barker DJ. In utero programming of cardiovascular disease. Theriogenology. 2000;53(2):555–74.
5. Hauth JC et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol. 2000;95(1):24–8.
6. Garovic VD, Hayman SR. Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol. 2007;3(11):613–22.
7. Villar J et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol. 2006;194(4):921–31.
8. Kvehaugen AS, Andersen LF, Staff AC. Anthropometry and cardiovascular risk factors in women and offspring after pregnancies complicated by preeclampsia or diabetes mellitus. Acta Obstet Gynecol Scand. 2010;89(11):1478–85.
9. Lykke JA et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53(6):944–51.
10. Ferreira I, Peeters LL, Stehouwer CD. Preeclampsia and increased blood pressure in the offspring: meta-analysis and critical review of the evidence. J Hypertens. 2009;27(10):1955–9.
11. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31. Revised ACOG hypertension in pregnancy definitions and management guidelines.
12. Stuart JJ et al. Maternal recall of hypertensive disorders in pregnancy: a systematic review. J Womens Health (Larchmt). 2013;22(1):37–47.
13. Block-Abraham DM et al. First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation. Obstet Gynecol. 2014;123(3):611–7.
14. Bushnell C, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1545–88.
15. Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013;71 Suppl 1:S18–25.
16. Cohen AL et al. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014;33(1):81–92.
17. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart. 1997;77(2):154–8.
18. Magnussen EB et al. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol. 2009;114(5):961–70.
19. Marin R et al. Long-term prognosis of hypertension in pregnancy. Hypertens Pregnancy. 2000;19(2):199–209.
20. Wilson BJ et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003;326(7394):845.
21. Sibai BM et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol. 1997;177(5):1003–10.
22. Dunne F et al. Pregnancy in women with type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med. 2003;20(9):734–8.
23. Hubel CA et al. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol. 1996;174(3):975–82.
24. Al MD et al. The essential fatty acid status of mother and child in pregnancy-induced hypertension: a prospective longitudinal study. Am J Obstet Gynecol. 1995;172(5):1605–14.
25. Girouard J et al. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension. 2007;49(5):1056–62.
26. Callaway LK et al. Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: findings from a prospective cohort study. Am J Obstet Gynecol. 2007;197(5):492.e1–7.
27. Carr DB et al. Preeclampsia and risk of developing subsequent diabetes. Hypertens Pregnancy. 2009;28(4):435–47.
28. Libby G et al. Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort. Diabetologia. 2007;50(3):523–30.
29. Valdiviezo C, Garovic VD, Ouyang P. Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk. Clin Cardiol. 2012;35(3):160–5. Review article evaluated the maternal cardiovascular risks in patients who had hypertensive disorder in pregnancy.
30. Bellamy L et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.
31. McDonald SD et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156(5):918–30.
32. Agatisa PK et al. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004;286(4):H1389–93.
33. Lampinen KH et al. Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens. 2006;24(4):751–6.
34. Ramsay JE et al. Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG. 2003;110(11):1029–31.
35. Jayet PY et al. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation. 2010;122(5):488–94.
36. Sandvik MK et al. Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol. 2013;209(6):569.e1–569.e10. Prospective study that evaluated flow-mediated brachial artery dilation and intima-media thickness of the carotid artery along with circulating markers of endothelial function. Found that endothelial function was altered in patients with preeclampsia compared to control cohort.
37. Staff AC, Dechend R, Redman CW. Review: Preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses. Placenta. 2013;34(Suppl):S73–8. Review article that evaluated increased risk for atherosclerosis and later chronic arterial disease in patients with preeclampsia.
38. ACOG Practice Bulletin No. 134: fetal growth restriction. Obstet Gynecol. 2013;121(5):1122–33.
39. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986;1(8489):1077–81.
40. Conde-Agudelo A et al. Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis. BJOG. 2013;120(6):681–94.
41. Davis EF et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics. 2012;129(6):e1552–61.
42. Gaillard R et al. Placental vascular dysfunction, fetal and childhood growth, and cardiovascular development: the generation R study. Circulation. 2013;128(20):2202–10.
43. Gebb J, Dar P. Colour Doppler ultrasound of spiral artery blood flow in the prediction of pre-eclampsia and intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol. 2011;25(3):355–66.
44. Mu M et al. Birth weight and subsequent blood pressure: a meta-analysis. Arch Cardiovasc Dis. 2012;105(2):99–113.
45. Ojeda NB, Grigore D, Alexander BT. Developmental programming of hypertension: insight from animal models of nutritional manipulation. Hypertension. 2008;52(1):44–50.
46. Spence D et al. Intra-uterine growth restriction and increased risk of hypertension in adult life: a follow-up study of 50-year-olds. Public Health. 2012;126(7):561–5.
47. Poston L, Hanson M. Developmental origins of health and disease. In: Creasy RR, Greene MF, Iams JD, Lockwood CJ, Moore TR, editors. Creasy and Resnik's maternal-fetal medicine: principles and practice. Philadelphia: Elsevier/Saunders; 2014. p. 139–45.
48. Barker DJP. Fetal origins of adult disease. In: Polin WWFRA, Abman S, editors. Fetal and neonatal physiology. Philadelphia: W.B. Saunders; 2004. p. 160–5.
49. Barker DJ. Outcome of low birthweight. Horm Res. 1994;42(4–5):223–30.
50. Barker DJ. Fetal origins of coronary heart disease. BMJ. 1995;311(6998):171–4.
51. Szostak-Wegierek D, Szamotulska K. Fetal development and risk of cardiovascular diseases and diabetes type 2 in adult life. Med Wieku Rozwoj. 2011;15(3):203–15.
52. Ryckman KK et al. Pregnancy complications and the risk of metabolic syndrome for the offspring. Curr Cardiovasc Risk Rep. 2013;7(3):217–23.
53. Anderson CM et al. Placental insufficiency leads to developmental hypertension and mesenteric artery dysfunction in two generations of Sprague-Dawley rat offspring. Biol Reprod. 2006;74(3):538–44.
54. Ness RB, Catov J. Invited commentary: timing and types of cardiovascular risk factors in relation to offspring birth weight. Am J Epidemiol. 2007;166(12):1365–7.
55. Nenov VD et al. Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens. 2000;9(2):85–97.
56. Contag SA et al. Developmental effect of antenatal exposure to betamethasone on renal angiotensin II activity in the young adult sheep. Am J Physiol Renal Physiol. 2010;298(4):F847–56.
57. Goddard KA et al. Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum Hered. 2007;63(1):1–16.
58. Millis RM. Epigenetics and hypertension. Curr Hypertens Rep. 2011;13(1):21–8. Review article that evaluates the evidence for epigenetic contributions to hypertension and complex environment and gene interactions that may explain the wide diversity of health and disease.
59. Anderson CM, et al. DNA methylation as a biomarker for preeclampsia. Biol Res Nurs. 2013. doi:10.1177/1099800413508645. Prospective study, one of the first to identify maternal epigenetic targets in fetal-derived tissue representing biomarkers for early detection and heritable risk of preeclampsia.
60. Koleganova N, Piecha G, Ritz E. Prenatal causes of kidney disease. Blood Purif. 2009;27(1):48–52.
61. Boyd HA et al. Associations of personal and family preeclampsia history with the risk of early-, intermediate- and late-onset preeclampsia. Am J Epidemiol. 2013;178(11):1611–9. Large Denmark study that showed strong familial associations for early- and intermediate-onset of preeclampsia in female relatives with strongest association in early-onset preeclampsia.
62. Arngrimsson R et al. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol. 1990;97(9):762–9.
63. Myklestad K et al. Hypertensive disorders in pregnancy and paternal cardiovascular risk: a population-based study. Ann Epidemiol. 2011;21(6):407–12.
64. Lazdam M et al. Unique blood pressure characteristics in mother and offspring after early onset preeclampsia. Hypertension. 2012;60(5):1338–45.
65. Resnik R, Creasy R. Intrauterine growth restriction. In: Creasy R, Greene MF, Iams JD, Lockwood CJ, Moore TR, editors. Creasy & Resnik’s maternal-fetal medicine: principles and practice. Philadelphia: Elsiever Saunders; 2014. p. 743–55.
66. Ahmad AS, Samuelsen SO. Hypertensive disorders in pregnancy and fetal death at different gestational lengths: a population study of 2 121 371 pregnancies. BJOG. 2012;119(12):1521–8.
67. Zetterstrom K et al. The association of maternal chronic hypertension with perinatal death in male and female offspring: a record linkage study of 866,188 women. BJOG. 2008;115(11):1436–42.
68. Mamun AA et al. Does hypertensive disorder of pregnancy predict offspring blood pressure at 21 years? Evidence from a birth cohort study. J Hum Hypertens. 2012;26(5):288–94. Large cohort study that found that maternal hypertensive disorder of pregnancy predicts adult offspring blood pressure.
69. Funai EF et al. Long-term mortality after preeclampsia. Epidemiology. 2005;16(2):206–15.
70. Irgens HU et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323(7323):1213–7.
71. Oglaend B et al. Blood pressure in early adolescence in the offspring of preeclamptic and normotensive pregnancies. J Hypertens. 2009;27(10):2051–4.
72. Smith GD et al. Birth dimensions of offspring, premature birth, and the mortality of mothers. Lancet. 2000;356(9247):2066–7.
73. Catov JM et al. Association between infant birth weight and maternal cardiovascular risk factors in the health, aging, and body composition study. Ann Epidemiol. 2007;17(1):36–43.
74. Romundstad PR et al. Associations of prepregnancy cardiovascular risk factors with the offspring's birth weight. Am J Epidemiol. 2007;166(12):1359–64.
75. Langford HG, Watson RL. Prepregnant blood pressure, hypertension during pregnancy, and later blood pressure of mothers and offspring. Hypertension. 1980;2(4 Pt 2):130–3.
76. Zetterstrom K et al. Chronic hypertension as a risk factor for offspring to be born small for gestational age. Acta Obstet Gynecol Scand. 2006;85(9):1046–50.
77. Bujold E et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116(2 Pt 1):402–14.
78. Geyl C, et al. Links between preeclampsia and intrauterine growth restriction. Gynecol Obstet Fertil. 2014;42(4):229–33.
79. Weiler J, Tong S, Palmer KR. Is fetal growth restriction associated with a more severe maternal phenotype in the setting of early onset pre-eclampsia? A retrospective study. PLoS One. 2011;6(10):e26937.
80. Burton GJ, Charnock-Jones DS, Jauniaux E. Regulation of vascular growth and function in the human placenta. Reproduction. 2009;138(6):895–902. Placental deficient conversion of the maternal spiral arteries is associated with the majority of pregnancy complications including preeclampsia. This effect increases the risk of spontaneous vasoconstriction of the arteries, and predisposes the placenta to ischemia reperfusion-type injury.
81. Markham KB, FE. Pregnancy related hypertension. In: Creasy R, Greene MF, Iams JD, Lockwood CJ, Moore TR, editors. Creasy and Resnik's maternal-fetal medicine: principles and practice. Elsiever Saunders: Philadelphia; 2014. p. 756–81.
82. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu. 1972;1:177–91.
83. Odegard RA et al. Preeclampsia and fetal growth. Obstet Gynecol. 2000;96(6):950–5.
84. Kajantie E et al. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke. 2009;40(4):1176–80.
85. Miettola S et al. Offspring's blood pressure and metabolic phenotype after exposure to gestational hypertension in utero. Eur J Epidemiol. 2013;28(1):87–98.
86. Fugelseth D et al. Myocardial function in offspring 5-8 years after pregnancy complicated by preeclampsia. Early Hum Dev. 2011;87(8):531–5.
87. Wu CS et al. Diseases in children born to mothers with preeclampsia: a population-based sibling cohort study. Am J Obstet Gynecol. 2011;204(2):157.e1–5.
88. Lawlor DA et al. Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children. Eur Heart J. 2012;33(3):335–45.
89. Kvehaugen AS et al. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension. 2011;58(1):63–9.
90. Whitehouse AJ et al. Do hypertensive diseases of pregnancy disrupt neurocognitive development in offspring? Paediatr Perinat Epidemiol. 2012;26(2):101–8.
91. Tuovinen S et al. Hypertensive disorders in pregnancy and risk of severe mental disorders in the offspring in adulthood: the Helsinki Birth Cohort Study. J Psychiatr Res. 2012;46(3):303–10.
92. Robinson M et al. Hypertensive diseases of pregnancy and the development of behavioral problems in childhood and adolescence: the Western Australian Pregnancy Cohort Study. J Pediatr. 2009;154(2):218–24.
93. Palti H, Rothschild E. Blood pressure and growth at 6 years of age among offsprings of mothers with hypertension of pregnancy. Early Hum Dev. 1989;19(4):263–9.
94. Vatten LJ et al. Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring. Obstet Gynecol. 2003;101(3):529–33.
95. Seidman DS et al. Pre-eclampsia and offspring's blood pressure, cognitive ability and physical development at 17-years-of-age. Br J Obstet Gynaecol. 1991;98(10):1009–14.
96. Tenhola S et al. Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia. J Clin Endocrinol Metab. 2003;88(3):1217–22.
97. Ophir E et al. Newborns of pre-eclamptic women: a biochemical difference present in utero. Acta Obstet Gynecol Scand. 2006;85(10):1172–8.
98. Palmsten K, Buka SL, Michels KB. Maternal pregnancy-related hypertension and risk for hypertension in offspring later in life. Obstet Gynecol. 2010;116(4):858–64.
99. Geelhoed JJ et al. Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures: the Avon Longitudinal Study of Parents and Children. Circulation. 2010;122(12):1192–9. One of the largest prospective cohort studies to evaluate the association between hypertensive disorders of pregnancy blood pressure of offspring.